Ute Bissels

Summary

Country: Germany

Publications

  1. pmc MicroRNAs are shaping the hematopoietic landscape
    Ute Bissels
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    Haematologica 97:160-7. 2012
  2. pmc Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells
    Ute Bissels
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    Stem Cells 29:847-57. 2011
  3. pmc RNA-based, transient modulation of gene expression in human haematopoietic stem and progenitor cells
    Yvonne Diener
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    Sci Rep 5:17184. 2015
  4. pmc Absolute quantification of microRNAs by using a universal reference
    Ute Bissels
    Miltenyi Biotec GmbH, 51429 Bergisch Gladbach, Germany
    RNA 15:2375-84. 2009
  5. pmc The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features
    Andrea Aloia
    Miltenyi Biotec GmbH, Friedrich Ebert Strasse 68, 51429, Bergisch Gladbach, Germany
    Breast Cancer Res 17:146. 2015

Collaborators

  • Yeong Hoon Choi
  • Thomas Tuschl
  • Olaf Hardt
  • Andreas Trumpp
  • Wolfgang Wagner
  • Andreas Bosio
  • Andrea Aloia
  • Yvonne Diener
  • Bernhard Gerstmayer
  • Jean Gabriel Judde
  • Monica Falleni
  • Britta Kandil
  • Franziska Maria Zickgraf
  • Marion Jurk
  • Olivier Déas
  • Steve Wagner
  • Silvia Rüberg
  • David Agorku
  • Marc Sutterlin
  • Laura Soldati
  • Saskia Spaich
  • Manuel Reitberger
  • Stefan Wild
  • Stefan Tomiuk
  • Stefano Cairo
  • Massimo Saini
  • Martin Ronald Sprick
  • Andreas Schneeweiss
  • Sebastian Knöbel
  • Evgeniya Petrova
  • Annalisa Terranegra

Detail Information

Publications5

  1. pmc MicroRNAs are shaping the hematopoietic landscape
    Ute Bissels
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    Haematologica 97:160-7. 2012
    ..This review summarizes our current knowledge about miRNA expression in hematopoietic stem and progenitor cells, and their role in the hematopoietic stem cell niche...
  2. pmc Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells
    Ute Bissels
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    Stem Cells 29:847-57. 2011
    ..These results are highly relevant for stem cell-based therapies with CD133(+) cells and delineate for the first time how the stem cell character of CD133(+) cells is defined by the expression of specific miRNAs...
  3. pmc RNA-based, transient modulation of gene expression in human haematopoietic stem and progenitor cells
    Yvonne Diener
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    Sci Rep 5:17184. 2015
    ..Our data provide a broad-ranging comparison of transfection methods for hard-to-transfect cells and offer new opportunities for DNA-free, non-integrating gene modulation in HSPCs. ..
  4. pmc Absolute quantification of microRNAs by using a universal reference
    Ute Bissels
    Miltenyi Biotec GmbH, 51429 Bergisch Gladbach, Germany
    RNA 15:2375-84. 2009
    ..We demonstrate the accuracy of the method by various spike-in experiments. Furthermore, we quantified miRNA copy numbers in liver samples and CD34(+)/CD133(-) hematopoietic progenitor cells...
  5. pmc The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features
    Andrea Aloia
    Miltenyi Biotec GmbH, Friedrich Ebert Strasse 68, 51429, Bergisch Gladbach, Germany
    Breast Cancer Res 17:146. 2015
    ..The aim of this study was to identify and evaluate biomarkers of treatment-resistant tumor cells...